ME

Healthcare · Pharmaceuticals

Medicamen Biotech Ltd (MEDICAMEQ)

₹286.00

Mkt cap
₹405 Cr
P/E ratio
35.00
P/B
1.38
Div yield
0.35%
ROE
3.95%
ROCE
5.82%
EPS (TTM)
₹8.17
Book value
₹208
52W range
210–454
Sector
Healthcare

Price history

Previous close

Incorporated in 1993, Medicamen Biotech Ltd is a research-led pharmaceutical company involved in developing, manufacturing, and marketing generic finished dosage formulations, and Oncology Formulations [1]

NSE MEDICAMEQBSE 531146
Health check
Cautious
ValuationFair
ProfitabilityWeak
GrowthModerate
52-week range
₹286
₹210₹454
Current
₹286.00
Prev close
—
Day
—

Financials

Revenue, profit & margin
P/E ratio
35.0×
MEDICAMEQ is 8% above the sector median of 32.5×
MEDICAMEQ35.0×
Sector median32.5×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales43.5446.5047.3243.0544.7445.1429.6143.0447.1746.9160.6547.9054.83
YoY Sales growth+29.85%+30.69%+22.37%+2.65%+2.76%-2.92%-37.43%-0.02%+5.43%+3.92%+104.83%+11.29%+16.24%
Expenses38.8941.6041.5739.6039.4338.4331.2238.4342.0142.5355.2243.5746.15
Operating Profit4.654.905.753.455.316.71-1.614.615.164.385.434.338.68
OPM %10.68%10.54%12.15%8.01%11.87%14.86%-5.44%10.71%10.94%9.34%8.95%9.04%15.83%
Other Income0.550.830.570.590.290.145.230.470.370.531.740.860.00
Interest0.910.651.890.711.040.760.651.150.990.970.380.831.69
Depreciation1.821.801.771.772.612.210.481.801.861.831.731.791.87
Profit before tax2.473.282.661.561.953.882.492.132.682.115.062.575.12
Tax %39.68%38.11%22.93%48.72%53.85%24.74%25.30%24.88%21.27%22.27%12.06%28.40%19.53%
Net Profit1.472.032.040.800.912.921.871.602.121.644.451.854.12
EPS in Rs1.191.901.681.061.152.731.901.591.971.612.851.562.51
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −2.24% · closed higher next day 1 of last 2
 Q1FY27Q2FY27
Broadcast14 Aug '26◦13 Nov '26◦
Earnings day−8.55%+4.08%
+1 day−6.12%+3.55%
+5 days−2.88%—
+15 days+16.14%—
+30 days+33.92%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Oct 2026
42.57%Promoter
Promoters42.57%2.11
FIIs4.35%0.14
DIIs0.00%
Public53.01%1.99
Government0.05%
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,884.9036.704,51,5380.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,180.5086.862,96,8070.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,689.5082.071,78,1800.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,294.6092.691,24,1950.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,200.0026.481,19,9900.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,390.2041.561,16,3600.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,415.0036.881,14,5180.92%852−35.05%7,404−2.44%15.49%
Medicamen Biotec₹285.9035.014050.35%4+27.72%55+16.24%5.82%
Median: 160 Co.₹432.2032.471,9870.08%13+33.73%179+21.23%14.94%

Filings